| 2360 |
Activation of steroidogenesis
Short Name
steroidogenesis
|
0 |
Cellular |
Sep 2, 2025 |
Sep 2, 2025 |
None
|
| 2359 |
HPG axis
Short Name
HPG axis
|
0 |
Molecular |
Aug 29, 2025 |
Aug 29, 2025 |
None
|
| 2358 |
endocrine disruption
Short Name
endocrine disruption
|
0 |
Molecular |
Aug 29, 2025 |
Aug 29, 2025 |
None
|
| 2357 |
ovary
Short Name
ovary retardation
|
0 |
Molecular |
Aug 29, 2025 |
Aug 29, 2025 |
None
|
| 2356 |
vitellogenin
Short Name
vtg
|
0 |
Molecular |
Aug 29, 2025 |
Aug 29, 2025 |
None
|
| 2355 |
Disrupted, Spermatogenesis and Sperm quality
Short Name
Disrupted, Spermatogenesis and Sperm quality
|
0 |
Organ |
Aug 16, 2025 |
Aug 16, 2025 |
592: DBDPE-induced DNA strand breaks and LDH activity inhibition leading to population growth rate decline via energy metabolism disrupt and apoptosis
|
| 2354 |
Activation, Apoptosis signaling
Short Name
Activation, Apoptosis signaling
|
0 |
Cellular |
Aug 16, 2025 |
Aug 16, 2025 |
592: DBDPE-induced DNA strand breaks and LDH activity inhibition leading to population growth rate decline via energy metabolism disrupt and apoptosis
|
| 2353 |
Disrupted, energy metabolism
Short Name
Disrupted, energy metabolism
|
0 |
Cellular |
Aug 16, 2025 |
Aug 16, 2025 |
592: DBDPE-induced DNA strand breaks and LDH activity inhibition leading to population growth rate decline via energy metabolism disrupt and apoptosis
|
| 2315 |
Increased, Incidence of cardiovascular disease
Short Name
Increased, Incidence of cardiovascular disease
|
0 |
Population |
Mar 11, 2025 |
Mar 11, 2025 |
None
|
| 2351 |
Increased, OXPHOS
Short Name
Increased, OXPHOS
|
0 |
Cellular |
Aug 16, 2025 |
Aug 16, 2025 |
592: DBDPE-induced DNA strand breaks and LDH activity inhibition leading to population growth rate decline via energy metabolism disrupt and apoptosis
|
| 2350 |
Decreased, Glycolysis
Short Name
Decreased, Glycolysis
|
0 |
Cellular |
Aug 16, 2025 |
Aug 16, 2025 |
592: DBDPE-induced DNA strand breaks and LDH activity inhibition leading to population growth rate decline via energy metabolism disrupt and apoptosis
|
| 2349 |
Inhibition of LDH activity
Short Name
Inhibition of LDH activity
|
0 |
Molecular |
Aug 16, 2025 |
Aug 16, 2025 |
592: DBDPE-induced DNA strand breaks and LDH activity inhibition leading to population growth rate decline via energy metabolism disrupt and apoptosis
|
| 2348 |
Inhibition, Liver regeneration
Short Name
Inhibition, Liver regeneration
|
0 |
Organ |
Aug 16, 2025 |
Aug 16, 2025 |
591: DBDPE-induced DNA damage increase in liver leading to Non-alcoholic fatty liver disease via liver steatosis and inhibition of regeneration
|
| 2347 |
Increase, Lipid degradation
Short Name
Increase, Lipid degradation
|
0 |
Cellular |
Aug 16, 2025 |
Aug 16, 2025 |
591: DBDPE-induced DNA damage increase in liver leading to Non-alcoholic fatty liver disease via liver steatosis and inhibition of regeneration
|
| 2346 |
Decrease, Proliferating Cell Nuclear Antigen
Short Name
Downregulation, PCNA
|
0 |
Molecular |
Aug 16, 2025 |
Aug 16, 2025 |
591: DBDPE-induced DNA damage increase in liver leading to Non-alcoholic fatty liver disease via liver steatosis and inhibition of regeneration
|
| 2345 |
Activation, MAPK
Short Name
Activation, MAPK
|
0 |
Molecular |
Aug 16, 2025 |
Aug 16, 2025 |
591: DBDPE-induced DNA damage increase in liver leading to Non-alcoholic fatty liver disease via liver steatosis and inhibition of regeneration
|
| 2344 |
Upregulation, growth arrest and DNA-damage-inducible beta a
Short Name
Upregulation, gadd45ba
|
0 |
Molecular |
Aug 16, 2025 |
Aug 16, 2025 |
591: DBDPE-induced DNA damage increase in liver leading to Non-alcoholic fatty liver disease via liver steatosis and inhibition of regeneration
|
| 2343 |
Cuproptosis, increased
Short Name
Cuproptosis, increased
|
0 |
Cellular |
Aug 13, 2025 |
Oct 16, 2025 |
590: Increase of intracellular copper leading to cuproptosis via interference with energy metabolism
|
| 2281 |
Increased uncoordinated cardiac contraction
Short Name
uncoordinated cardiac contraction
|
0 |
Tissue |
Nov 20, 2024 |
Nov 26, 2024 |
552: Inhibiton of L-Type Calcium Channels leading to heart failure via QT interval prolongation and Torsades de Pointes (TdP)
|
| 2287 |
Impaired Sodium-Calcium Exchange
Short Name
Impaired Sodium-Calcium Exchange
|
0 |
Cellular |
Nov 21, 2024 |
Nov 21, 2024 |
556: Decreased Na/K ATPase activity leading to heart failure
|
| 2288 |
Phosphodiesterase inhibition
Short Name
Phosphodiesterase (PDE)
|
0 |
Molecular |
Nov 22, 2024 |
Nov 22, 2024 |
558: Phosphodiesterase inhibition leading to heart failure
|
| 2289 |
Hyperphosphorylation of ryanodine receptor (RyR2)
Short Name
RyR2 hyperphosphorylation
|
0 |
Cellular |
Nov 22, 2024 |
Nov 22, 2024 |
558: Phosphodiesterase inhibition leading to heart failure
|
| 2290 |
Inhibition of Funny current (If)
Short Name
if
|
0 |
Molecular |
Nov 22, 2024 |
Nov 22, 2024 |
560: Inhibition of Funny current (If) leading to Arrhythmias
|
| 2291 |
Slowed Heart Rate
Short Name
Bradycardia
|
0 |
Tissue |
Nov 22, 2024 |
Nov 25, 2024 |
2 AOPs
|
| 2292 |
Altered Cardiac Electrical Conduction
Short Name
Altered Cardiac Electrical Conduction
|
0 |
Organ |
Nov 22, 2024 |
Nov 22, 2024 |
2 AOPs
|